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SUMMARY. Primary malignant melanoma of the female urethra is a rare tumor that most commonly affects meatus and 
the distal urethra. The prognosis is poor. We report the case of 65-year-old woman who was refered by a gynaecologist 
due to an urethral mass mimicking a caruncule. The tumor was removed by a local exscision, and pathological analysis 
revealed malignant melanoma. After three months distal urethrectomy was performed with no evidence of residual 
 tumor. The patient was uneventful during 6-year follow up period.
Prikaz bolesnice
Klju~ne rije~i: `enska uretra, maligni melanom
SA`ETAK. Primarni maligni melanom ̀ enske uretre je rijedak tumor. Naj~e{}e je lokaliziran u meatusu i distalnom  dijelu 
uretre. Prognoza je lo{a. Prikazujemo {ezdesetpetogodi{nju bolesnicu upu}enu od ginekologa zbog tumorske promjene 
uretre nalik karunkulu. Tumor je odstranjen lokalnom ekscizijom, a patohistolo{kim pregledom je postavljena dijagnoza 
malignog melanoma. Nakon tri mjeseca u~injena je resekcija donje tre}ine uretre, pri ~emu tumor nije na|en. Bolesnica 
je bez znakova recidiva, odnosno metastatskog {irenja bolesti i nakon {est godina klini~kog pra}enja.
Introduction
The most frequent locations of primary malignant 
melanoma are the skin and eye, while malignant mel-
noma of the lower female genitourinary tract is an un-
common malignancy.1,2
The urethra is the most common site of origin in pri-
mary malignant melanoma of the genitourinary tract. 
Most malignant melanomas of the female urethra are lo-
cated at the meatus or in the distal urethra. Urethral me-
lanoma shows its peak incidence in the older age group, 
the average patient’s age is 63 years. The disease is three 
times more common in women than men.3–5
Reed6 reported the first case of primary malignant 
melanoma of the female urethra in 1896. The tumor is 
usually pigmented, varying in colour from black to blue 
or light brownish lesions, which are firm, nodular, and 
often ulcerated. Grossly, the tumour may be easily con-
fused with a caruncule.7 Primary malignant melanoma 
of the female urethra tends to metastasize at the early 
stage via the superficial lymphatics to the vulva and va-
gina, by the deep lymphatics to the inguinal lymph 
nodes and occasionally to distant sites by the haematog-
enous route. Survival depends on the stage, location and 
size of the neoplasm at the time of diagnosis. Histologi-
cal characteristics do not affect the prognosis signifi-
cantly and all histological types are treated in a similar 
manner.8,9 Despite major surgery, radiotherapy or im-
munotherapy; malignant melanoma usually has a poor 
prognosis.10 Most patients do not survive more than 
three years. Only eleven patients have been reported so 
far who lived for 4 years and more.4 We report an ad-
ditional case of patient who is alive and well after 6 
years.
Case report
A 65-year-old woman was refered by a gynaecologist 
due to an urethral mass with a gross apperance of a ca-
runcule. Upon examination, a 3-cm wide, pedunculated, 
black pigmented, friable and hemorrhagic polyp was 
found at the posterior wall of the urethral meatus. The 
tumor was removed by a local excision. Histopathologic 
anlysis revealed polypoid tumor with surface partialy 
ulcerated and partialy covered with squamous and tran-
sitional epitehelia (Fig. 1). The tumor was composed of 
loosely cohesive nests of atypical epiteheloid and spin-
dle shaped melanocytes showing diffuse and nested 
growth pattern. The neoplastic cells had abundant eo-
sinophilic cytoplasm, large hyperchromatic nuclei with 
prominent nucleoli, and brisk mitotic activity (15/10 
HPF). Most of the tumor cells contained coarsly granu-
lar melanocytic pigment (Fig. 2). Depth of tumor inva-
sion, measured by digital microscopic camera Olympus 
DP10 is 3.57 mm. No vascular/lymphatic invasion was 
seen histologically. Immunohistochemically tumor cells 
showed strong cytoplasmatic reactivity for HMB45 
(Fig. 3).
The clinical examination revealed no history of pre-
vious cutaneous biopsy or existance of recent suspicious 
pigmented lesion of other localization, and a diagnosis 
of primary mealnoma was rendered. The low third re-
section of distal urethra was performed, in another insti-
tution, three months after initial surgery, with no evi-
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Figure 1. Polypoid, partially ulcerated melanoma of the female urethra 
(H&E ×40).
Slika 1. Polipoidni, djelomice ulcerirani melanom `enske uretre 
(H&E×40).
Figure 3. HMB45 expression in melanoma cells
(HMB45, MSIP ×200).
Slika 3. HMB45 ekspresija u stanicama melanoma
(HMB45, MSTP × 200).
Figure 2. Nests of atypical melanocytes with the large nuclei showing 
prominent nucleoli, and numerous mitotic figures (H&E ×400).
Slika 2. Gnijezda atipi~nih melanocita s velikim jezgrama koje pokazuju 
istaknute nukleole i brojne mitoti~ke figure (H&E × 400).
dence of residual tumor. Initial metastatic evaluation, 
including computerized tomography scan of the chest, 
abdomen and pelvis revealed no evidence of dissemi-
nated disease. Computerized tomography two years 
 after initial diagnosis revealed two enlarged right para-
iliacal lymph nodes which remained unchanged at two 
subsequent CT controls performed four and six years 
later. The patient was uneventful during 6-year follow-
up period.
Disscusion
Melanocytes are neural crest-derived cells located in 
the basal layer of skin, hair follicles, most squamous-
covered mucosal membranes, leptomeninges, and sev-
eral other sites. Their function is to produce an insoluble 
pigment known as melanin using tyrosine as a substrate 
and to transfer this product through the process of cyto-
crinia to the adjacent epithelial cells. Ultrastructurally, 
the hallmark of the melanocytes is the melanin-synthe-
sizing organelle known as the melanosome.11 Malignant 
melanoma is the tumor composed of atypical melano-
cytes. Histogenesis of melanomas arising in mucous 
membranes still remains in dispute and several theories 
have been proposed. In some animals it has been clearly 
demonstrated that melanoblasts originating from the 
neural rests may subsequently migrate with mesoder-
mal cells to sites where they usually not exist. A possi-
ble alternative mechanism is the so-called »melanogen-
ic-metaplasia« of the epithelium, in other words meta-
plasia of squamous and glandular epithelium into 
pigment-producing cells. Finally, neural crest elements 
may be transformed into melanocytes and nevus cells.
Primary malignant melanomas of the genitourinary 
tract are a very rare tumors, and represent less than 1% 
of all melanomas.12 The tumor usually arises in the dis-
tal portion of the urethra. Symptoms of urethral melano-
mas rapidly develop and are not distinctive. They in-
clude urethral mass, nonspecific perineal pain, dysuria, 
frequency, incontinence, hematuria or local bleeding.3 
The prognosis is poor. Metastases to the inguinal lymph 
nodes occur early in the course of the disease, in 50% 
of the cases being already present at the time of the di-
agnosis. Rapid disseminaton renders treatment very dif-
ficult in spite of an early diagnosis.4
The thickness of the tumor and the mitotic index have 
to be taken into account on microscopic examination, 
since tumors more than 1.5 mm thick and with more 
than one mitotic figure in every high power field carry a 
worse prognosis.13,14 Metastatic melanoma should be 
excluded, so detailed history, careful examination of 
skin, and evaluation of other visceral primary sites are 
required to confirm the primary nature of the lesion. 
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The presence of junctional activity in the area adjacent 
to the lesion is of primary importance in this determina-
tion. Histological appearance includes the whole range 
seen at other primary sites, including diffuse, nested, 
fascicular, and storiform patterns. Amelanotic melano-
mas cause the greatest diagnostic challenge, so epithe-
liotropism as well as pagetoid spread suggested a pri-
mary melanoma.12 Urethral melnoma should be dif-
ferentiated from benign pigmented lesions including 
genital lentiginosis, atypical melanocytic nevi and atyp-
ical lentiginous hyperplasia. Differential diagnosis in-
clude sarcoma, spindle cell carcinoma, small cell carci-
noma, lymphoma and plasmocytoma.12–15
Two problems in planning the treatment should be 
recognized: local control and prevention of systemic 
disease. The local control is primarily surgical. Kim et 
al.15 suggested that total urethrectomy with bilateral in-
guinal lymph node dissection should be the initial treat-
ment in patients without evident distant metastases. 
Some authors recommend even more radical therapy in-
cluding pelvic exenteration in case of melanoma with 
depth of penetration more than 3 mm.16 Some authors 
suggest adjuvant treatment with β-interferon and sys-
temic chemotherapy.17
According to our knowledge 89 cases have been re-
ported in literature, but only few authors reported sur-
vival longer than 6 years.18 Glenn reported the first case 
in 1953, of 45-year old woman with stage D
1
 disease 
that underwent subtotal urethrectomy and lymph node 
dissection, and lived for 13 years without recurrent tu-
mour.19 In 1976 Katz reported a case of primary mela-
noma of urethra and bladder neck (stage C
3
). Following 
radiotherapy and surgery patient survived disease-free 
for 10 years.3 Another case of a patient with stage A 
primary malignant melanoma was reported by Mayer in 
1987. Patient underwent partial urethrectomy and vul-
vectomy and remained disease-free for 15 years.20
Despite adverse histological features revealed in our 
case (brisk mitotic activity, necrosis, depth of invasion) 
and conservative treatment, our patient is still alive and 
uneventful after 6 years. Therefore we presume that 
conventional histopathological prognostic factors (tu-
mour depth, level of invasion, mitotic rate, and ulcer-
ation) do not play as important role in predicting out-
come and biological behaviour in the primary malignant 
melanoma of the female urethra as in the primary skin 
melanomas. In addition, more recently defined criteria, 
such as presence of melanoma cells in the peripheral 
blood have been shown to correlate with prognosis and 
overall survival as well.12,21 However all of the above-
mentioned criteria are limited in their ability to predict 
outcome that is universally dependent on early diagno-
sis and subsequent aggressive surgery intervention.
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